Melflufen therapy for relapsed refractory multiple myeloma (RRMM) patients refractory to daratumumab and/or pomalidomide: A report on early efficacy Meeting Abstract


Authors: Mateos, M. V.; Bladé, J.; Larocca, A.; Oriol, A.; Rodriguez, P.; Alegre, A.; Cavo, M.; Moreb, J. S.; Paner, A.; Gabrail, N.; Halka, K. G.; Hassoun, H.; Maisel, C.; Mazumder, A.; Zonder, J. A.; Ocio, E. M.; Byrne, C.; Harmenberg, J.; Thuresson, S.; Nordstrom, E.; Lindberg, J.; Richardson, P. G.
Abstract Title: Melflufen therapy for relapsed refractory multiple myeloma (RRMM) patients refractory to daratumumab and/or pomalidomide: A report on early efficacy
Meeting Title: 59th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 130
Issue: Suppl. 1
Meeting Dates: 2017 Dec 9-12
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2017-12-07
Language: English
ACCESSION: WOS:000432419404285
PROVIDER: wos
Notes: Meeting Abstract: 1841 -- Source: Wos
MSK Authors
  1. Hani Hassoun
    143 Hassoun
Related MSK Work